Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name CPI-1205
Trade Name
Drug Descriptions

CPI-1205 inhibits EZH2, including both wild-type and mutant forms, potentially resulting in decreased tumor growth (PMID: 27739677, PMID: 29905573).

DrugClasses EZH2 inhibitor 20
CAS Registry Number 621862-70-1
NCIT ID C121639


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abiraterone + CPI-1205 + Prednisone Abiraterone CPI-1205 Prednisone 0 1
CPI-1205 CPI-1205 0 1
CPI-1205 + Enzalutamide CPI-1205 Enzalutamide 0 1
CPI-1205 + Ipilimumab CPI-1205 Ipilimumab 0 1

Additional content available in CKB BOOST